首页> 外文期刊>Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society >Contrast-enhanced ultrasound for the evaluation of hepatic artery stenosis after liver transplantation: Potential role in changing the clinical algorithm
【24h】

Contrast-enhanced ultrasound for the evaluation of hepatic artery stenosis after liver transplantation: Potential role in changing the clinical algorithm

机译:超声造影评价肝移植后肝动脉狭窄的作用:改变临床算法的潜在作用

获取原文
获取原文并翻译 | 示例
           

摘要

Hepatic artery stenosis (HAS) is a common complication in liver transplant patients. Conventional angiography remains the gold standard for diagnosis. Recently, contrast-enhanced ultrasound (CEUS) has begun providing real-time angiographiclike images of vessels and allowing the accurate diagnosis of arterial diseases such as hepatic artery thrombosis. The purpose of this study was to evaluate the efficacy of CEUS in depicting HAS after liver transplantation. Forty-seven liver transplant recipients underwent CEUS examinations with the intravenous injection of microbubble contrast agents. The reference standard was conventional angiography for 15 patients and computed tomographic angiography for 32 patients. The presence, degree, location, and type of HAS were evaluated. For the detection of HAS by CEUS, the following was found: an accuracy of 91.5% (43/47), a sensitivity of 92.3% (36/39), a specificity of 87.5% (7/8), a positive predictive value of 97.3% (36/37), and a negative predictive value of 70% (7/10). CEUS corrected false-positive findings on color Doppler ultrasound in 7 of 47 cases (14.9%). The accuracy of CEUS in identifying the location and type of HAS was 92.3% (36/39) and 84.6% (33/39), respectively. CEUS is a useful noninvasive technique for the detection of HAS in liver transplant patients because it provides comprehensive information, including the presence, location, degree, and type. A positive CEUS finding suggests angiography as the next step rather than a computed tomography scan and may thereby alter the clinical imaging algorithm.
机译:肝动脉狭窄(HAS)是肝移植患者的常见并发症。常规血管造影术仍然是诊断的金标准。最近,造影剂增强超声(CEUS)已开始提供血管的实时血管造影图像,并可以准确诊断动脉疾病,例如肝动脉血栓形成。这项研究的目的是评估CEUS描绘肝移植后HAS的功效。静脉注射微泡造影剂对47位肝移植受者进行了CEUS检查。参考标准为15例患者常规血管造影和32例计算机断层血管造影。评估了HAS的存在,程度,位置和类型。对于通过CEUS检测HAS,发现以下结果:准确度为91.5%(43/47),灵敏度为92.3%(36/39),特异性为87.5%(7/8),阳性预测值的预测值为97.3%(36/37),阴性预测值为70%(7/10)。 CEUS纠正了47例中的7例(14.9%)的彩色多普勒超声假阳性结果。 CEUS识别HAS的位置和类型的准确性分别为92.3%(36/39)和84.6%(33/39)。 CEUS是用于检测肝移植患者中HAS的有用的非侵入性技术,因为它提供了包括存在,位置,程度和类型在内的全面信息。 CEUS的阳性结果提示血管造影是下一步,而不是计算机断层扫描,因此可能会改变临床成像算法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号